Coronation 发表于 2025-3-23 09:55:43

http://reply.papertrans.cn/1/47/4697/4697-11.png

敏捷 发表于 2025-3-23 17:24:42

Submitted on: 15 June 2023.
Revised on: 07 August 2023.
Accepted on: 28 August 2023.

___________________CANCER IMMUNOLOGY IMMUNOTHERAPY

Chagrin 发表于 2025-3-23 19:03:38

Submitted on: 09 April 2011.
Revised on: 24 May 2011.
Accepted on: 21 July 2011.

___________________CANCER IMMUNOLOGY IMMUNOTHERAPY

Cosmopolitan 发表于 2025-3-24 02:10:51

http://reply.papertrans.cn/1/47/4697/4697-14.png

合并 发表于 2025-3-24 03:09:37

http://reply.papertrans.cn/1/47/4697/4697-15.png

Tractable 发表于 2025-3-24 07:38:23

http://reply.papertrans.cn/1/47/4697/4697-16.png

考博 发表于 2025-3-24 14:44:18

Submitted on: 12 June 2021.
Revised on: 01 August 2021.
Accepted on: 22 September 2021.

___________________CANCER IMMUNOLOGY IMMUNOTHERAPY

GRIEF 发表于 2025-3-24 16:58:30

http://reply.papertrans.cn/1/47/4697/4697-18.png

万神殿 发表于 2025-3-24 19:38:01

http://reply.papertrans.cn/1/47/4697/4697-19.png

athlete’s-foot 发表于 2025-3-25 01:49:45

Submitted on: 02 September 2012.
Revised on: 28 December 2012.
Accepted on: 27 January 2013.

___________________CANCER IMMUNOLOGY IMMUNOTHERAPY
页: 1 [2] 3 4
查看完整版本: SCIE期刊CANCER IMMUNOLOGY IMMUNOTHERAPY 2024/2025影响因子:4.605 (CANCER IMMUNOL IMMUN) (0340-7004). (ONCOLOGY)(肿瘤学)Science Ci